Related Experiment Videos
[Aceruloplasminemia].
1First Department of Medicine, Hamamatsu University School of Medicine.
Rinsho Shinkeigaku = Clinical Neurology
|July 24, 2001
Summary
Aceruloplasminemia is a rare genetic disorder causing iron buildup in the brain and eyes, leading to neurological issues, vision loss, and diabetes. It results from mutations in the ceruloplasmin gene, impacting iron metabolism.
Area of Science:
- Biochemistry
- Genetics
- Neuroscience
Context:
- Ceruloplasmin, an alpha 2-serum glycoprotein, transports most copper in human plasma and is synthesized in the liver.
- Aceruloplasminemia is an autosomal recessive disorder characterized by iron accumulation due to a deficiency in ceruloplasmin's ferroxidase activity.
Purpose:
- To describe the clinical manifestations and underlying molecular pathology of aceruloplasminemia.
- To highlight the role of ceruloplasmin in iron homeostasis and its impact on neurological and systemic health.
Summary:
- Aceruloplasminemia presents clinically as a triad of neurological disease, retinal degeneration, and diabetes mellitus.
- Mutations in the ceruloplasmin gene lead to iron deposition in the basal ganglia, retina, and other tissues, causing neurodegeneration and systemic symptoms.
- Ceruloplasmin deficiency uniquely affects the central nervous system, distinguishing it from other iron storage disorders.
Impact:
- Understanding aceruloplasminemia provides insights into iron metabolism's role in neurological function and disease.
- This research emphasizes ceruloplasmin's critical role in maintaining iron homeostasis and preventing neurodegeneration.
- Identifying the specific genetic cause and clinical triad aids in diagnosing and managing this rare disorder.